Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Statistics

Total Valuation

TPEX:6620 has a market cap or net worth of TWD 11.92 billion. The enterprise value is 8.20 billion.

Market Cap	11.92B
Enterprise Value	8.20B

Important Dates

The next estimated earnings date is Thursday, August 13, 2026.

Earnings Date	Aug 13, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6620 has 165.53 million shares outstanding. The number of shares has increased by 13.32% in one year.

Current Share Class	165.53M
Shares Outstanding	165.53M
Shares Change (YoY)	+13.32%
Shares Change (QoQ)	+6.12%
Owned by Insiders (%)	1.52%
Owned by Institutions (%)	2.18%
Float	96.01M

Valuation Ratios

The trailing PE ratio is 14.86.

PE Ratio	14.86
Forward PE	n/a
PS Ratio	6.78
PB Ratio	2.25
P/TBV Ratio	2.62
P/FCF Ratio	36.84
P/OCF Ratio	33.23
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.33, with an EV/FCF ratio of 25.34.

EV / Earnings	10.50
EV / Sales	4.66
EV / EBITDA	7.33
EV / EBIT	8.58
EV / FCF	25.34

Financial Position

The company has a current ratio of 8.91, with a Debt / Equity ratio of 0.01.

Current Ratio	8.91
Quick Ratio	8.87
Debt / Equity	0.01
Debt / EBITDA	0.04
Debt / FCF	0.14
Interest Coverage	475.27

Financial Efficiency

Return on equity (ROE) is 16.42% and return on invested capital (ROIC) is 42.64%.

Return on Equity (ROE)	16.42%
Return on Assets (ROA)	11.28%
Return on Invested Capital (ROIC)	42.64%
Return on Capital Employed (ROCE)	17.63%
Weighted Average Cost of Capital (WACC)	8.62%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.33
Inventory Turnover	n/a

Taxes

In the past 12 months, TPEX:6620 has paid 196.27 million in taxes.

Income Tax	196.27M
Effective Tax Rate	20.09%

Stock Price Statistics

The stock price has decreased by -12.83% in the last 52 weeks. The beta is 0.80, so TPEX:6620's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	-12.83%
50-Day Moving Average	72.62
200-Day Moving Average	93.12
Relative Strength Index (RSI)	45.73
Average Volume (20 Days)	467,874

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6620 had revenue of TWD 1.76 billion and earned 780.80 million in profits. Earnings per share was 4.85.

Revenue	1.76B
Gross Profit	1.49B
Operating Income	952.45M
Pretax Income	977.07M
Net Income	780.80M
EBITDA	1.10B
EBIT	952.45M
Earnings Per Share (EPS)	4.85

Balance Sheet

The company has 3.77 billion in cash and 46.00 million in debt, with a net cash position of 3.72 billion or 22.49 per share.

Cash & Cash Equivalents	3.77B
Total Debt	46.00M
Net Cash	3.72B
Net Cash Per Share	22.49
Equity (Book Value)	5.29B
Book Value Per Share	31.91
Working Capital	3.81B

Cash Flow

In the last 12 months, operating cash flow was 358.67 million and capital expenditures -35.18 million, giving a free cash flow of 323.49 million.

Operating Cash Flow	358.67M
Capital Expenditures	-35.18M
Depreciation & Amortization	150.10M
Net Borrowing	-13.19M
Free Cash Flow	323.49M
FCF Per Share	1.95

Margins

Gross margin is 84.83%, with operating and profit margins of 54.18% and 44.41%.

Gross Margin	84.83%
Operating Margin	54.18%
Pretax Margin	55.58%
Profit Margin	44.41%
EBITDA Margin	62.71%
EBIT Margin	54.18%
FCF Margin	18.40%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 2.78%.

Dividend Per Share	2.00
Dividend Yield	2.78%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	30.26%
Buyback Yield	-13.32%
Shareholder Yield	-10.54%
Earnings Yield	6.55%
FCF Yield	2.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4